期刊名称：ONCOLOGIST
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
MISSION AND BELIEFS
The practice of oncology and hematology is more challenging than ever before. Physicians are charting new territories in cancer patient care and practice management. The Oncologist?/SUP> was established by oncologists to help physicians better manage their practices in a changing and challenging environment to guard against the future and ensure their patient's rights to the best health care possible.
The Oncologist is devoted to medical and practice issues for surgical, radiation, and medical oncologists and is designed specifically for the busy practitioner entrusted with the care of adult or pediatric cancer patients. With emphasis on clear, concise interpretation, this international peer-reviewed journal publishes original papers, reviews, and commentaries addressing the multimodality diagnosis, treatment, and quality of life of the cancer patient. Manuscripts are reviewed by two or more experts in the field and, when accepted, are published with haste—generally within 12 weeks. When a contribution is of such relevance as to significantly impact public health, authors may request Fast Track Review for a Rapid Communication, in which case an editorial decision will be made within 2 weeks of submission.
The journal's articles are meant to impact the practice of oncology and to facilitate significant communication in the introduction of new medical treatments and technologies. Emphasizing the interpretation rather than the data, The Oncologist's Senior Editors believe that the various oncology subspecialists should share the same information base and read the same journal. As cancer specialists, we should resist the trend to capitulate our responsibilities in disease management to payers, gatekeepers, and hospital administrators. It is up to us to defend the patient's needs and rights and to assure that the patient has an advocate. In order to do so, we have to be united and fully informed. We pledge to put the best and latest information on cancer management before our readership, to help prepare them for the future , and to do their best as a team for every patient.
To this end, The Oncologist challenges its readers to understand what is new and better, to glimpse the future, not only in terms of research, but also in terms of new team approaches to disease management. In short, we want our readers to explore how cancer medicine could be and will be practiced now and throughout the 21st century.
CORRESPONDENCE
Editorial correspondence, including submissions for publication or letters to the Editor, should be addressed to the Executive Editor. Submissions for publication in the Fundamentals in Cancer Medicine section should also be addressed to the Executive Editor.
Information for Authors can be found at the back of each issue, or contact the AlphaMed Press Editorial Office.
Advertising: Correspondence and rate requests should be addressed to the Publisher.
Change of Address notices: Both the subscriber's old and new address should be e-mailed to AlphaMed Press at least one month in advance. You can also mail the information to: AlphaMed Press, c/o Cambey & West, PO Box 412, Congers, New York 10920-9914 USA.
About the journal
桌
Information for Authors.pdf
Instructions to Authors
Informations for Author
The Oncologist is designed specifically for the busy, practicing oncologist and hematologist entrusted with the care of cancer patients. With its emphasis on clear interpretation rather than extensive data, this international peer-reviewed journal publishes original papers, reviews, and commentaries addressing the multimodality diagnosis and treatment of the cancer patient.
More details see the PDF file below.
Instructions to Authors
Submission Instructions.pdf
1083-7159.pdf
Editorial Board
EDITOR-IN-CHIEF
Bruce A. Chabner
Massachusetts General Hospital
Harvard Medical School
Boston, MA
SENIOR EDITORS
Medical Oncology
Gregory A. Curt
The Oncologist
H.M. Pinedo
Free University Hospital
Amsterdam, The Netherlands
Pediatric Oncology
Frank M. Balis *
National Cancer Institute
Bethesda, MD
Radiotherapeutic Oncology
Eli Glatstein
University of Pennsylvania
Philadelphia, PA
Surgical Oncology
John E. Niederhuber
University of Wisconsin
Comprehensive Cancer Center
Madison, WI
Raphael E. Pollock
University of Texas
M.D. Anderson Cancer Center
Houston, TX
EXECUTIVE EDITOR
Martin J. Murphy, Jr.
Telephone: 937-291-2355
CME CO-EDITORS
Gregory A. Curt
The Oncologist
Frank M. Balis
National Cancer Institute
Bethesda, MD
CME ASSOCIATE EDITOR
Charles R. Sherman
National Institute of Health
Bethesda, MD
SECTION EDITORS
Acute and Chronic Leukemias
and Multiple Myeloma
George P. Canellos
Boston, MA
Breast Cancer
Jose Baselga
Barcelona, Spain
Breast Cancer
Gabriel N. Hortobágyi
Houston, TX
Cancer Biology
David S. Goodsell
La Jolla, CA
Cancer Imaging
Gregory Sorensen
Boston, MA Clinical Genetics and Genetic Counseling
Ilan R. Kirsch
Bethesda, MD
Clinical Pharmacology
Jan H.M. Schellens
Amsterdam, The Netherlands Clinical Pharmacology
Frank Balis
Bethesda, MD Clinical Pharmacology
Mace L. Rothenberg
Nashville, TN
Diagnostics
Andrew T. Turrisi, III
Detroit, MI Diagnostics
Fred R. Hirsch
Denver, CO Gastrointestinal Cancer
Patrick G. Johnston
Belfast, Northern Ireland
Gastrointestinal Cancer
Peter J. O'Dwyer
Philadephia, PA Genitourinary Cancer
Howard I. Scher
New York, NY Gynecologic Oncology
Peter G. Harper
London, United Kingdom
Gynecologic Oncology
William Hoskins
Savannah, GA Head and Neck Cancers
Marshall Posner
Boston, MA Head and Neck Cancers
Jan B. Vermorken
Edegem, Belgium
Hepatobiliary
Kenneth K. Tanabe
Boston, MA Hepatobiliary
Ren?Adam
Villejuif, France Immunotherapy, Monoclonals, and Vaccines
Michael T. Lotze, III
Pittsburgh, PA
Lung Cancer
Cesare Gridelli
Avellino, Italy Lung Cancer
Thomas J. Lynch, Jr.
Boston, MA Lymphoma
Michael L. Grossbard
New York, NY
Medical Ethics
Joseph J. Fins
New York, NY Medical Ethics
Gerd Richter
Marburg, Germany Melanoma and Cutaneous Malignancies
Frank G. Haluska
Boston, MA
Melanoma and Cutaneous Malignancies
Alexander M.M. Eggermont
Rotterdam, The Netherlands Neuro-Oncology
Howard Fine
Bethesda, MD Neuro-Oncology
Charles J. Vecht
The Hague, The Netherlands
Pediatric Oncology
Susan M. Blaney
Houston, TX Prevention
Frank L. Meyskens, Jr.
Orange, CA Prevention
Hans-Joerg Senn
Saint Gallen, Switzerland
Radiation Oncology
Nancy Price Mendenhall
Gainesville, FL Sarcomas
Peter W. Pisters
Houston, TX Symptom Management and Supportive Care
Stein Kaasa
Trondheim, Norway
Symptom Management and Supportive Care
Russell K. Portenoy
New York, NY
--------------------------------------------------------------------------------
EDITORIAL BOARD
Matti S. Aapro
Genolier, Switzerland
Keisuke Aiba
Tokyo, Japan
Carmen J. Allegra
North Potomac, MD
James O. Armitage
Omaha, NE Rodrigo Arriagada
Santiago, Chile Susan E. Bates
Bethesda, MD
Joseph R. Bertino
New Brunswick, NJ Douglas W. Blayney
Ann Arbor, MI Andrew Bottomley
Brussels, Belgium
Nai-Kong V. Cheung
New York, NY Hernán Cortés-Funes
Madrid, Spain Nancy A. Dawson
Baltimore, MD
Volker Diehl
Köln, Germany Ross C. Donehower
Baltimore, MD Timothy J. Eberlein
St. Louis, MO
David S. Ettinger
Baltimore, MD Alison G. Freifeld
Omaha, NE Giuseppe Giaccone
Amsterdam, The Netherlands
F. Anthony Greco
Nashville, TN Jayne S. Gurtler
Metairie, LA John Hainsworth
Nashville, TN
Louis B. Harrison
New York, NY Michael J. Haut
Philadelphia, PA Michael J. Hawkins
Santa Monica, CA
Christian Herfarth
Heidelberg, Germany John A. Hohneker
East Hanover, NJ Lyonel G. Israels
Winnipeg, Manitoba, Canada
Dwight Kaufman
Jackson, TN Maccon M. Keane
Galway, Ireland Peter Kozuch
New York, NY
Beverly J. Lange
Philadelphia, PA Jay Loeffler
Boston, MA Judy E. Lundgren
Ft. Worth, TX
Langdon L. Miller
South Plainfield, NJ Franco M. Muggia
New York, NY Hamza Mujagic
Tuzla, Bosnia
William A. Nahhas
Dayton, OH David R. Newell
Newcastle upon Tyne, United Kingdom Seamus O’Reilly
Cork, Ireland
Joyce O’Shaughnessy
Dallas, TX Roger J. Packer
Washington, DC Nicholas Pavlidis
Ioannina, Greece
Richard Pazdur
Rockville, MD Richard T. Penson
Boston, MA Steve Piantadosi
Baltimore, MD
Karl C. Podratz
Rochester, MN Gregory H. Reaman
Washington, DC Eddie Reed
Morgantown, WV
Patrick Remington
Madison, WI Paula Trahan Rieger
Alexandria, VA Leslie L. Robison
Minneapolis, MN
Rafael Rosell
Badalona, Spain Valerie W. Rusch
New York, NY Nagahiro Saijo
Tokyo, Japan
Richard L. Schilsky
Chicago, IL Gilberto Schwartsmann
Porto Alegre, Brazil Peter E. Schwartz
New Haven, CT
Michael Seiden
Boston, MA Eric J. Small
San Francisco, CA Lawrence A. Solberg
Jacksonville, FL
Margaret F. Spittle
London, United Kingdom Jeffrey Supko
Boston, MA Joel E. Tepper
Chapel Hill, NC
Lars-Erik Tisell
Göteborg, Sweden Umberto Veronesi
Milan, Italy Jaap Verweij
Rotterdam, The Netherlands
Howard J. Weinstein
Boston, MA Raymond B. Weiss
Rockville, MD Ralph Weissleder
Charlestown, MA
Wyndham Wilson
Bethesda, MD Stanley H. Winokur
Atlanta, GA
EDITORIAL OFFICE
Managing Editor
Ann Murphy
Telephone: 919-402-8730
Supervisor, Editorial Services
Elaine Ingram
Editorial Assistant
Nicole
Send manuscripts and correspondence to:
Dr. Martin J. Murphy, Jr.
Executive Editor
The Oncologist
AlphaMed Press
One Prestige Place, Suite 290
Miamisburg, Ohio 45342-3758, USA
Telephone: 937-291-2355
Fax: 937-291-4229
e-mail: Submissions@TheOncologist.com
Website: www.TheOncologist.com
|
